AR044129A1 - Compuestos intermedios de imidazopiridina. proceso de preparacion. - Google Patents
Compuestos intermedios de imidazopiridina. proceso de preparacion.Info
- Publication number
- AR044129A1 AR044129A1 ARP040101460A ARP040101460A AR044129A1 AR 044129 A1 AR044129 A1 AR 044129A1 AR P040101460 A ARP040101460 A AR P040101460A AR P040101460 A ARP040101460 A AR P040101460A AR 044129 A1 AR044129 A1 AR 044129A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- hydrogen
- alkoxycarbonyl
- halogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 11
- 239000001257 hydrogen Substances 0.000 abstract 11
- -1 (C1-4) -alkyl Chemical group 0.000 abstract 8
- 229910052736 halogen Inorganic materials 0.000 abstract 8
- 150000002367 halogens Chemical class 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 4
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 2
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 abstract 1
- CPEONABTMRSIKA-UHFFFAOYSA-N 1,4$l^{2}-oxazinane Chemical compound C1COCC[N]1 CPEONABTMRSIKA-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicación 1: Un compuesto de la fórmula (1), en la cual: R1 es hidrógeno, (C1-4)-alquilo, (C3-7)-cicloalquilo, (C3-7)-cicloalquil-(C1-4)-alquilo, (C1-4)-alcoxi, (C1-4)-alcoxi-(C1-4)-alquilo, (C1-4)-alcoxicarbonilo, (C2-4)-alquenilo, (C2-4)-alquinilo, fluoro-(C1-4)-alquilo o hidroxi-(C1-4)-alquilo; R2 es hidrógeno, (C1-4)-alquilo, arilo, (C3-7)-cicloalquilo, (C3-7)-cicloalquil-(C1-4)-alquilo, (C1-4)-alcoxicarbonilo, hidroxi-(C1-4)-alquilo, halógeno, (C2-4)-alquenilo, (C2-4)-alquinilo, fluoro-(C1-4)-alquilo cianometilo; R3a es hidrógeno, halógeno, fluoro-(C1-4)-alquilo, (C1-4)-alquilo, (C2-4)-alquenilo, (C2-4)-alquinilo, carboxilo, (C1-4)-alcoxicarbonilo, hidroxi-(C1-4)-alquilo, (C1-4)-alcoxi-(C1-4)-alquilo, (C1-4)-alcoxi-(C1-4)-alcoxi-(C1-4)-alquilo, fluoro-(C1-4)-alcoxi-(C1-4)-alquilo o el radical -CO-NR31R32; R3b es hidrógeno, halógeno, fluoro-(C1-4)-alquilo, (C1-4)-alquilo, (C2-4)-alquenilo, (C2-4)-alquinilo, carboxilo, (C1-4)-alcoxicarbonilo, hidroxi-(C1-4)-alquilo, (C1-4)-alcoxi-(C1-4)-alquilo, (C1-4)-alcoxi-(C1-4)-alcoxi-(C1-4)-alquilo, fluoro-(C1-4)-alcoxi-(C1-4)-alquilo o el radical -CO-NR31R32, donde R31 es hidrógeno, (C1-7)-alquilo, hidroxi-(C1-4)-alquilo o (C1-4)-alcoxi-(C1-4)-alquilo; y R32 es hidrógeno, (C1-7)-alquilo, hidroxi-(C1-4)-alquilo o (C1-4)-alquiloxi-(C1-4)-(C1-4)-alquilo, o donde R31 y R32 juntos, con inclusión del átomo de nitrógeno al cual están unidos ambos, son un radical pirrolidino, piperidino, piperazino, N-(C1-4)-alquil-piperazino o morfolino; Arom es un radical aromático mono- o bicíclico sustituido con R4, R5, R6 y R7, que se selecciona del grupo constituido por fenilo, naftilo, pirrolilo, pirazolilo, imidazolilo, 1,2,3-triazolilo, indolilo, bencimidazolilo, furanilo (furilo), benzofuranilo (benzofurilo), tiofenilo (tienilo), benzotiofenilo, (benzotienilo), tiazolilo, isoxazolilo, piridinilo, pirimidinilo, quinolinilo e isoquinolinilo, donde R4 es hidrógeno, (C1-4)-alquilo, hidroxi-(C1-4)-alquilo, (C1-4)-alcoxi, (C2-4)-alqueniloxi, (C1-4)-alquilcarbonilo, carboxilo, (C1-4)-alcoxicarbonilo, carboxi-(C1-4)-alquilo, (C1-4)-alcoxicarbonil-(C1-4)-alquilo, halógeno, hidroxilo, arilo, aril-(C1-4)-alquilo, ariloxi, aril-(C1-4)-alcoxi, trifluorometilo, nitro, amino, mono- o di-(C1-4)-alquilamino, (C1-4)-alquicarbonil-amino, (C1-4)-alcoxicarbonilamino, (C1-4)-alcoxi-(C1-4)-alcoxicarbonilamino o sulfonilo; R5 es hidrógeno, (C1-4)-alquilo, (C1-4)-alcoxi, (C1-4)-alcoxicarbonilo, halógeno, trifluorometilo o hidroxilo; R6 es hidrógeno, (C1-4)-alquilo o halógeno; y R7 es hidrógeno, (C1-4)-alquilo o halógeno, donde arilo es fenilo o fenilo sustituido que tiene uno, dos o tres sustituyentes idénticos o diferentes del grupo constituido por (C1-4)-alquilo, (C1-4)-alcoxi, carboxilo, (C1-4)-alcoxicarbonilo, halógeno, trifluorometilo, nitro, trifluorometoxi, hidroxilo y ciano; y sus sales. Reivindicación 7: El uso de compuestos de la fórmula (1) de acuerdo con la reivindicación 1, en la cual R1, R2, R3a, R3b y Arom tienen los significados indicados en la reivindicación 1, para la preparación de compuestos de la fórmula (2) o sus sales, en la cual R1, R2, R3a, R3b y Arom tienen los significados indicados en la reivindicación 1, y R8 es hidrógeno, (C1-4)-alquilo o arilo, donde arilo tiene el significado que se indica en la reivindicación 1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03010218 | 2003-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044129A1 true AR044129A1 (es) | 2005-08-24 |
Family
ID=33427041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101460A AR044129A1 (es) | 2003-05-06 | 2004-04-29 | Compuestos intermedios de imidazopiridina. proceso de preparacion. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7256293B2 (es) |
| EP (1) | EP1622905A1 (es) |
| JP (1) | JP2006525285A (es) |
| KR (1) | KR20060015541A (es) |
| CN (1) | CN1780834A (es) |
| AR (1) | AR044129A1 (es) |
| AU (1) | AU2004235981A1 (es) |
| BR (1) | BRPI0410056A (es) |
| CA (1) | CA2524259A1 (es) |
| CL (1) | CL2004000951A1 (es) |
| IS (1) | IS8151A (es) |
| MX (1) | MXPA05011594A (es) |
| NO (1) | NO20055699L (es) |
| PE (1) | PE20050149A1 (es) |
| RS (1) | RS20050811A (es) |
| TW (1) | TW200504075A (es) |
| WO (1) | WO2004099203A1 (es) |
| ZA (1) | ZA200507861B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ541836A (en) | 2003-02-27 | 2008-12-24 | Palau Pharma Sa | Pyrazolopyridine derivatives |
| TWI387603B (zh) | 2005-07-20 | 2013-03-01 | Merck Sharp & Dohme | Ｈｃｖ ｎｓ３蛋白酶抑制劑 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU736767B2 (en) | 1997-05-28 | 2001-08-02 | Altana Pharma Ag | Fused dihydropyrans |
| CA2404466A1 (en) | 2000-03-29 | 2001-10-04 | Altana Pharma Ag | Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders |
| CN1221553C (zh) | 2000-03-29 | 2005-10-05 | 奥坦纳医药公司 | 三环咪唑并吡啶类化合物及药物组合物 |
| KR100860627B1 (ko) | 2000-03-29 | 2008-09-29 | 니코메드 게엠베하 | 이미다조피리딘 유도체의 프로드러그 |
| HRP20020853A2 (en) | 2000-03-29 | 2005-02-28 | Altana Pharma Ag | Alkylated imidazopyridine derivatives |
| KR20040011423A (ko) | 2000-10-25 | 2004-02-05 | 알타나 파마 아게 | 위액 분비 억제제로서의 다중치환된 이미다조피리딘 |
| WO2003014120A1 (en) | 2001-08-03 | 2003-02-20 | Altana Pharma Ag | Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| EP1419156A1 (en) | 2001-08-03 | 2004-05-19 | ALTANA Pharma AG | Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| HRP20040229A2 (en) | 2001-08-10 | 2005-02-28 | Altana Pharma Ag | Tricyclic imidazopyridines |
-
2004
- 2004-04-29 AR ARP040101460A patent/AR044129A1/es not_active Application Discontinuation
- 2004-05-03 PE PE2004000444A patent/PE20050149A1/es not_active Application Discontinuation
- 2004-05-04 MX MXPA05011594A patent/MXPA05011594A/es not_active Application Discontinuation
- 2004-05-04 CL CL200400951A patent/CL2004000951A1/es unknown
- 2004-05-04 KR KR1020057020449A patent/KR20060015541A/ko not_active Withdrawn
- 2004-05-04 AU AU2004235981A patent/AU2004235981A1/en not_active Abandoned
- 2004-05-04 EP EP04731016A patent/EP1622905A1/en not_active Withdrawn
- 2004-05-04 WO PCT/EP2004/050693 patent/WO2004099203A1/en not_active Ceased
- 2004-05-04 CN CNA2004800114219A patent/CN1780834A/zh active Pending
- 2004-05-04 BR BRPI0410056-5A patent/BRPI0410056A/pt not_active IP Right Cessation
- 2004-05-04 US US10/555,057 patent/US7256293B2/en not_active Expired - Fee Related
- 2004-05-04 CA CA002524259A patent/CA2524259A1/en not_active Abandoned
- 2004-05-04 JP JP2006505586A patent/JP2006525285A/ja not_active Withdrawn
- 2004-05-04 RS YUP-2005/0811A patent/RS20050811A/sr unknown
- 2004-05-05 TW TW093112688A patent/TW200504075A/zh unknown
-
2005
- 2005-09-28 ZA ZA200507861A patent/ZA200507861B/xx unknown
- 2005-11-25 IS IS8151A patent/IS8151A/is unknown
- 2005-12-02 NO NO20055699A patent/NO20055699L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1622905A1 (en) | 2006-02-08 |
| RS20050811A (sr) | 2007-12-31 |
| AU2004235981A1 (en) | 2004-11-18 |
| ZA200507861B (en) | 2008-08-27 |
| MXPA05011594A (es) | 2005-12-15 |
| JP2006525285A (ja) | 2006-11-09 |
| CN1780834A (zh) | 2006-05-31 |
| CL2004000951A1 (es) | 2005-03-04 |
| CA2524259A1 (en) | 2004-11-18 |
| NO20055699D0 (no) | 2005-12-02 |
| TW200504075A (en) | 2005-02-01 |
| KR20060015541A (ko) | 2006-02-17 |
| US7256293B2 (en) | 2007-08-14 |
| IS8151A (is) | 2005-11-25 |
| WO2004099203A8 (en) | 2007-04-26 |
| WO2004099203A1 (en) | 2004-11-18 |
| BRPI0410056A (pt) | 2006-05-23 |
| PE20050149A1 (es) | 2005-03-22 |
| US20060276499A1 (en) | 2006-12-07 |
| NO20055699L (no) | 2006-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201390032A1 (ru) | Композиции и способы модуляции сигнального пути wnt | |
| MX2016012984A (es) | Derivados indol para uso en medicina. | |
| EA201892450A1 (ru) | Ароматические сульфонамидные производные | |
| DK1520175T3 (da) | Oncolytiske vira som midler til fænotypebestemmelse af neoplasmer | |
| PT3400748T (pt) | Padrões e esquemas de detecção de salto de frequência de canais físicos de acesso aleatório de banda estreita | |
| ECSP10010473A (es) | Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilización | |
| AR093020A1 (es) | Compuestos antiviricos para el vsr | |
| AR103561A1 (es) | Fenilpiridinas herbicidas | |
| IL241577B (en) | Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide | |
| AR083503A1 (es) | Colorantes bis-azo para usar como colorantes azules | |
| AR094537A1 (es) | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa | |
| MX2013006101A (es) | Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos. | |
| AR092348A1 (es) | DERIVADOS DE ARIL-SULTAMO COMO MODULADORES DE RORc | |
| AR095426A1 (es) | Inhibidores tripeptídicos de la epoxicetona proteasa | |
| JOP20210035A1 (ar) | توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns | |
| AR052069A1 (es) | Composiciones detergentes liquidas substancialmente no acuosas y su utilizacion | |
| AR076903A1 (es) | Material de empaque que comprende porciones magnetizables | |
| EP4065815A4 (en) | AUTOMATED DETECTION OF PLUG AND PERFORATION COMPLETIONS, WELLHEADS AND DRILLSITE OPERATING STATUS | |
| AR097866A1 (es) | Derivados de 4-azaindol | |
| AR070649A1 (es) | Derivados de 1,3- dihidro -isoindol | |
| EP3908288A4 (en) | Rnai agents for inhibiting expression of hif-2 alpha (epas1), compositions thereof, and methods of use | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| CL2016002089A1 (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| EP2938699A4 (en) | YELLOW GREEN TO YELLOW FLUORES BASED ON TERBIO-CONTAINING ALUMINUM | |
| EP4098656A4 (en) | PEPTIDE FOR INHIBITING THE FORMATION OF A SNARE COMPLEX AND USE THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |